Insider trades

Nathan L. Mata, Chief Officer of Belite Bio BLTE, has filed 0 purchases and 103 sales on the open market. Over the past 12 months that comes to a net sale of $2.7M. The latest trade was on 05/07.

Nathan L. Mata

Chief Scientific Officer
First filing
25/03/19
Trades
104 trades
Buys / sales
0 / 103
12-month net buying
−$2.7M
Last trade
05/07

Trading activity

Transactions

Trade type
BLTE
Open-market sale10b5-1 plan05/0705/08666 sh4 trades$153.21avg.$102,038.46−100.0%
BLTE
Open-market sale10b5-1 plan05/0605/071,000 sh6 trades$153.84avg.$153,837.8−60.0%
BLTE
Open-market sale10b5-1 plan05/0505/061,000 sh6 trades$155.50avg.$155,501.72−37.5%
BLTE
Open-market sale10b5-1 plan05/0405/051,000 sh5 trades$155.64avg.$155,638.12−27.3%
BLTE
Open-market sale10b5-1 plan05/0105/041,000 sh8 trades$155.78avg.$155,778.97−21.4%
BLTE
Open-market sale10b5-1 plan04/3005/011,000 sh4 trades$156.97avg.$156,974.54−17.6%
BLTE
Open-market sale10b5-1 plan04/2904/301,000 sh5 trades$155.82avg.$155,816.65−15.0%
BLTE
Open-market sale10b5-1 plan04/2804/291,000 sh9 trades$159.16avg.$159,162.45−13.0%
BLTE
Open-market sale10b5-1 plan04/2704/281,000 sh5 trades$162.64avg.$162,642.46−11.5%
BLTE
Open-market sale10b5-1 plan04/2404/271,000 sh6 trades$159.56avg.$159,556.39−10.3%
BLTE
Open-market sale10b5-1 plan04/2304/241,000 sh6 trades$166.28avg.$166,281.64−9.4%
BLTE
Open-market sale10b5-1 plan04/2204/231,000 sh9 trades$170.39avg.$170,385.25−8.6%
BLTE
Open-market sale10b5-1 plan04/2104/221,000 sh5 trades$166.00avg.$166,000.48−7.9%
BLTE
Open-market sale10b5-1 plan04/2004/211,000 sh7 trades$163.60avg.$163,596.12−7.3%
BLTE
Open-market sale10b5-1 plan04/16–04/1704/202,000 sh13 trades$161.01avg.$322,011.18−12.8%
BLTE
Open-market sale10b5-1 plan04/1504/161,000 sh5 trades$168.30avg.$168,295.94−6.0%